HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

methylmethionine ICG-Der-02

for infrared tumor imaging; structure in first source

Also Known As:

Met-ICG-Der-02; l-methyl-methionine ICG-Der-02

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Du, Changli: 1 article (12/2012)
2.	Gu, Yueqing: 1 article (12/2012)
3.	Jie, Cao: 1 article (12/2012)
4.	Mahounga, Didel M: 1 article (12/2012)
5.	Shan, Lingling: 1 article (12/2012)
6.	Wan, Shunan: 1 article (12/2012)

Related Diseases

1.	Neoplasms (Cancer) 12/01/2012 - "Met-ICG-Der-02 probe is a promising optical imaging agent for tumor diagnosis, especially in their early stage." 12/01/2012 - "Optical imaging showed a distinguishable fluorescence signal in the tumor area at 2 h while maximal tumor-to-normal tissue contrast ratio was at 12 h Met-ICG-Der-02 post-injection. " 12/01/2012 - "Cell experiments demonstrated excellent cellular uptake of Met-ICG-Der-02 on cancer cell lines without cytotoxicity. "
2.	Breast Neoplasms (Breast Cancer) 12/01/2012 - "The dynamics of Met-ICG-Der-02 was investigated in athymic nude mice prior to evaluation of the probe targeting capability in prostate and breast cancer models. "